A look at how peptides taken by mouth can survive the gut and still reach specific sites in the body, a key hurdle for pill versions of these drugs.
Recap by typeshit. Post by The News & Observer on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A look at how targeted peptides taken by mouth can survive the gut and still reach specific sites in the body. Details are in the full story.
The dermatology practice looks at why so many brands push peptides, and whether claims of firmer skin and fewer fine lines hold up.
Loading…